Interview: NCCIH Director Josephine Briggs On The Science Supporting More Self-Care
This article was originally published in The Tan Sheet
In an interview with “The Tan Sheet,” Briggs discusses topics including the lack of data on drug-supplement interactions and NCCIH’s interest in funding research on standards for assessing the clinical importance of those interactions.
You may also be interested in...
NCCIH Director Josephine Briggs will depart the center after nine years, with deputy director David Shurtleff serving as acting director; the 10th Circuit will not rehear MusclePharm's complaint against insurer; blood sugar supplement firm receives FDA warning letter; more news in brief.
National Center for Complementary and Alternative Medicines Director Josephine Briggs started in the post at a time when the center is expected to operate with no increase in federal funding, she says
With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.